分子靶向-话题@MedSci - 梅斯（MedSci）

#分子靶向#

34篇内容 | 1614人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1986928, encodeId=5ea01986928b0, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=CSCO 2014：晚期结直肠癌分子靶向治疗进展, objectType=article, longId=40529, objectId=0e03405298b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e03405298b, replyNumber=0, likeNumber=90, createdTime=2015-08-13, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e03405298b, moduleTitle=CSCO 2014：晚期结直肠癌分子靶向治疗进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0e03405298b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986930, encodeId=d2ae1986930a4, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=Cancer Discovery：利用新型分子靶向作用癌细胞生物钟来遏制癌症, objectType=article, longId=45057, objectId=718e4505ec9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=718e4505ec9, replyNumber=0, likeNumber=99, createdTime=2015-02-11, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=718e4505ec9, moduleTitle=Cancer Discovery：利用新型分子靶向作用癌细胞生物钟来遏制癌症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=718e4505ec9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986929, encodeId=1c96198692963, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=治疗转移性结直肠癌的分子靶向药物爱必妥®获批, objectType=article, longId=44535, objectId=301c445354e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=301c445354e, replyNumber=0, likeNumber=91, createdTime=2015-11-11, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=301c445354e, moduleTitle=治疗转移性结直肠癌的分子靶向药物爱必妥®获批, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=301c445354e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986926, encodeId=92a4198692651, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=晚期非小细胞肺癌分子靶向治疗专家共识（2013版）, objectType=article, longId=38731, objectId=cf0638e31e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf0638e31e4, replyNumber=0, likeNumber=87, createdTime=2014-09-27, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf0638e31e4, moduleTitle=晚期非小细胞肺癌分子靶向治疗专家共识（2013版）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cf0638e31e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986925, encodeId=4acb198692544, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=CSMO 2014 ：晚期肾癌分子靶向治疗研究进展, objectType=article, longId=37819, objectId=c61b3e819a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c61b3e819a7, replyNumber=0, likeNumber=85, createdTime=2014-12-17, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c61b3e819a7, moduleTitle=CSMO 2014 ：晚期肾癌分子靶向治疗研究进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c61b3e819a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986927, encodeId=8bcc198692e0d, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=CSCO 2014：大肠癌分子靶向治疗, objectType=article, longId=40437, objectId=489f4043e8d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=489f4043e8d, replyNumber=0, likeNumber=83, createdTime=2015-07-15, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=489f4043e8d, moduleTitle=CSCO 2014：大肠癌分子靶向治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=489f4043e8d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986924, encodeId=bf291986924da, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=肿瘤个体化分子靶向治疗进展, objectType=article, longId=26013, objectId=0e28260135b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e28260135b, replyNumber=0, likeNumber=108, createdTime=2014-09-17, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e28260135b, moduleTitle=肿瘤个体化分子靶向治疗进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0e28260135b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986922, encodeId=5f18198692241, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=HER2阳性晚期胃癌分子靶向治疗中国专家共识, objectType=article, longId=7423, objectId=96a9e42329, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96a9e42329, replyNumber=0, likeNumber=85, createdTime=2013-04-13, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96a9e42329, moduleTitle=HER2阳性晚期胃癌分子靶向治疗中国专家共识, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=96a9e42329)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986921, encodeId=90aa198692149, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=《HER2阳性晚期胃癌分子靶向治疗中国专家共识》草案摘要, objectType=article, longId=7132, objectId=47c5e132c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47c5e132c6, replyNumber=0, likeNumber=74, createdTime=2013-05-07, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47c5e132c6, moduleTitle=《HER2阳性晚期胃癌分子靶向治疗中国专家共识》草案摘要, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=47c5e132c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986923, encodeId=460b1986923ed, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=HER2阳性晚期胃癌分子靶向治疗中国专家共识, objectType=article, longId=10845, objectId=2cbd1084525, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cbd1084525, replyNumber=0, likeNumber=76, createdTime=2013-04-11, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cbd1084525, moduleTitle=HER2阳性晚期胃癌分子靶向治疗中国专家共识, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2cbd1084525)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986918, encodeId=08bf1986918cc, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=肿瘤新生血管及分子靶向治疗新策略, objectType=article, longId=3388, objectId=e7fa33881b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7fa33881b, replyNumber=0, likeNumber=75, createdTime=2012-06-17, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7fa33881b, moduleTitle=肿瘤新生血管及分子靶向治疗新策略, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e7fa33881b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986919, encodeId=1a6f198691959, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=2011年肿瘤分子诊断及分子靶向治疗回顾与展望, objectType=article, longId=3389, objectId=9754338920, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9754338920, replyNumber=0, likeNumber=72, createdTime=2012-05-10, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9754338920, moduleTitle=2011年肿瘤分子诊断及分子靶向治疗回顾与展望, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9754338920)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986920, encodeId=cf2d1986920ee, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=肿瘤分子靶向治疗药物研究进展, objectType=article, longId=3390, objectId=a1bb339089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1bb339089, replyNumber=0, likeNumber=75, createdTime=2012-06-05, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1bb339089, moduleTitle=肿瘤分子靶向治疗药物研究进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a1bb339089)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986917, encodeId=3de8198691ead, content=<a href='/topic/show?id=77dd31e07c0' target=_blank style='color:#2F92EE;'>#分子靶向#</a>, objectTitle=分子靶向治疗的关键：中靶或脱靶，及对临床的指导意义, objectType=article, longId=2466, objectId=937f24663e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=937f24663e, replyNumber=0, likeNumber=78, createdTime=2011-05-20, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=937f24663e, moduleTitle=分子靶向治疗的关键：中靶或脱靶，及对临床的指导意义, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=937f24663e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

分子靶向

2020-05-29

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

CSCO 2014：晚期结直肠癌分子靶向治疗进展

2015-08-13

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

Cancer Discovery：利用新型分子靶向作用癌细胞生物钟来遏制癌症

2015-02-11

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

治疗转移性结直肠癌的分子靶向药物爱必妥®获批

2015-11-11

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

晚期非小细胞肺癌分子靶向治疗专家共识（2013版）

2014-09-27

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

CSMO 2014 ：晚期肾癌分子靶向治疗研究进展

2014-12-17

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

CSCO 2014：大肠癌分子靶向治疗

2015-07-15

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

肿瘤个体化分子靶向治疗进展

2014-09-17

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

HER2阳性晚期胃癌分子靶向治疗中国专家共识

2013-04-13

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

《HER2阳性晚期胃癌分子靶向治疗中国专家共识》草案摘要

2013-05-07

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

HER2阳性晚期胃癌分子靶向治疗中国专家共识

2013-04-11

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

肿瘤新生血管及分子靶向治疗新策略

2012-06-17

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

2011年肿瘤分子诊断及分子靶向治疗回顾与展望

2012-05-10

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

肿瘤分子靶向治疗药物研究进展

2012-06-05

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#分子靶向#

分子靶向治疗的关键：中靶或脱靶，及对临床的指导意义

2011-05-20

科室
- - 订阅+
  - 更多科室
工具
服务